A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors Meeting Abstract
| Authors: | Ahnert, J. R.; Taylor, M. H.; O'Reilly, E. M.; Zhang, J.; Doebele, R. C.; Ben, Y.; Sharp, L. L.; Boyle, W. J.; Chang, C.; Frey, G.; Chen, W.; Melnick, M.; Short, J. M.; Burris, H. A. |
| Abstract Title: | A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 630s |
| Language: | English |
| ACCESSION: | WOS:000442916008053 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS12126 |
| Notes: | Meeting Abstract: TPS12126 -- Source: Wos |
